When compared to non-SS sicca subjects, the two most upregulated of these proteins in pSS patients, FKBP1A and CD44, play a role in adaptive immunity through T-cell activation and proliferation [54, 55], in addition to promoting tumour growth and progression. This evidence concerns the gene FKBP1A and neoplasm.